# Ollie's Bargain Outlet Holdings, Inc.: financial statements, quarterly

OLLI · Nasdaq · CIK 1639300 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/olli.md) · [Financials](/companies/olli/financials.md) · [Filings](/companies/olli/filings.md) · [Insiders](/companies/olli/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/olli/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [480](/filings/0001140361-24-048926.md) | [649 d](/filings/0001140361-26-010409.md) | [509](/filings/0001140361-25-021300.md) | [578](/filings/0001140361-25-033812.md) | [517](/filings/0001140361-25-045024.md) | [667 d](/filings/0001140361-26-010409.md) | [577](/filings/0001140361-26-023882.md) | [680](/filings/0001104659-26-104755.md) | [614](/filings/0001140361-25-045024.md) | [779 d](/filings/0001140361-26-010409.md) | [659](/filings/0001140361-26-023882.md) | [741](/filings/0001104659-26-104755.md) |
| Cost of revenue | $m | [286](/filings/0001140361-24-048926.md) | [386 d](/filings/0001140361-26-010409.md) | [299](/filings/0001140361-25-021300.md) | [359](/filings/0001140361-25-033812.md) | [303](/filings/0001140361-25-045024.md) | [395 d](/filings/0001140361-26-010409.md) | [340](/filings/0001140361-26-023882.md) | [408](/filings/0001104659-26-104755.md) | [360](/filings/0001140361-25-045024.md) | [468 d](/filings/0001140361-26-010409.md) | [383](/filings/0001140361-26-023882.md) | [419](/filings/0001104659-26-104755.md) |
| Gross profit | $m | [194](/filings/0001140361-24-048926.md) | [263 d](/filings/0001140361-26-010409.md) | [209](/filings/0001140361-25-021300.md) | [219](/filings/0001140361-25-033812.md) | [214](/filings/0001140361-25-045024.md) | [272 d](/filings/0001140361-26-010409.md) | [237](/filings/0001140361-26-023882.md) | [271](/filings/0001104659-26-104755.md) | [254](/filings/0001140361-25-045024.md) | [311 d](/filings/0001140361-26-010409.md) | [276](/filings/0001140361-26-023882.md) | [322](/filings/0001104659-26-104755.md) |
| Selling, general and administrative | $m | [142](/filings/0001140361-24-048926.md) | [156 d](/filings/0001140361-26-010409.md) | [142](/filings/0001140361-25-021300.md) | [146](/filings/0001140361-25-033812.md) | [154](/filings/0001140361-25-045024.md) | [170 d](/filings/0001140361-26-010409.md) | [165](/filings/0001140361-26-023882.md) | [175](/filings/0001104659-26-104755.md) | [180](/filings/0001140361-25-045024.md) | [188 d](/filings/0001140361-26-010409.md) | [189](/filings/0001140361-26-023882.md) | [197](/filings/0001104659-26-104755.md) |
| Operating income | $m | [39.1](/filings/0001140361-24-048926.md) | [97.7 d](/filings/0001140361-26-010409.md) | [56.5](/filings/0001140361-25-021300.md) | [60.8](/filings/0001140361-25-033812.md) | [44.5](/filings/0001140361-25-045024.md) | [87.7 d](/filings/0001140361-26-010409.md) | [56.2](/filings/0001140361-26-023882.md) | [77.0](/filings/0001104659-26-104755.md) | [55.4](/filings/0001140361-25-045024.md) | [109 d](/filings/0001140361-26-010409.md) | [69.6](/filings/0001140361-26-023882.md) | [108](/filings/0001104659-26-104755.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.2](/filings/0001140361-24-048926.md) | [25.8 d](/filings/0001140361-26-010409.md) | [14.5](/filings/0001140361-25-021300.md) | [15.7](/filings/0001140361-25-033812.md) | [12.7](/filings/0001140361-25-045024.md) | [23.2 d](/filings/0001140361-26-010409.md) | [13.4](/filings/0001140361-26-023882.md) | [20.2](/filings/0001104659-26-104755.md) | [13.8](/filings/0001140361-25-045024.md) | [28.4 d](/filings/0001140361-26-010409.md) | [18.1](/filings/0001140361-26-023882.md) | [29.2](/filings/0001104659-26-104755.md) |
| Net income | $m | [31.8](/filings/0001140361-24-048926.md) | [76.5 d](/filings/0001140361-26-010409.md) | [46.3](/filings/0001140361-25-021300.md) | [49.0](/filings/0001140361-25-033812.md) | [35.9](/filings/0001140361-25-045024.md) | [68.6 d](/filings/0001140361-26-010409.md) | [47.6](/filings/0001140361-26-023882.md) | [61.3](/filings/0001104659-26-104755.md) | [46.2](/filings/0001140361-25-045024.md) | [85.6 d](/filings/0001140361-26-010409.md) | [56.4](/filings/0001140361-26-023882.md) | [85.5](/filings/0001104659-26-104755.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001140361-24-048926.md) | not reported | [0.75](/filings/0001140361-25-021300.md) | [0.79](/filings/0001140361-25-033812.md) | [0.58](/filings/0001140361-25-045024.md) | not reported | [0.77](/filings/0001140361-26-023882.md) | [0.99](/filings/0001104659-26-104755.md) | [0.75](/filings/0001140361-25-045024.md) | not reported | [0.92](/filings/0001140361-26-023882.md) | [1.42](/filings/0001104659-26-104755.md) |
| Basic EPS | $ per share | [0.52](/filings/0001140361-24-048926.md) | not reported | [0.76](/filings/0001140361-25-021300.md) | [0.80](/filings/0001140361-25-033812.md) | [0.59](/filings/0001140361-25-045024.md) | not reported | [0.78](/filings/0001140361-26-023882.md) | [1.00](/filings/0001104659-26-104755.md) | [0.75](/filings/0001140361-25-045024.md) | not reported | [0.93](/filings/0001140361-26-023882.md) | [1.42](/filings/0001104659-26-104755.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [160](/filings/0001140361-24-048926.md) | [266](/filings/0001140361-25-010442.md) | [212](/filings/0001140361-25-021300.md) | [171](/filings/0001140361-25-033812.md) | [129](/filings/0001140361-25-045024.md) | [205](/filings/0001140361-26-010409.md) | [199](/filings/0001140361-26-023882.md) | [231](/filings/0001104659-26-104755.md) | [145](/filings/0001140361-25-045024.md) | [260](/filings/0001104659-26-104755.md) | [198](/filings/0001140361-26-023882.md) | [121](/filings/0001104659-26-104755.md) |
| Current assets | $m | [806](/filings/0001140361-24-048926.md) | [871](/filings/0001140361-25-010442.md) | [879](/filings/0001140361-25-021300.md) | [895](/filings/0001140361-25-033812.md) | [924](/filings/0001140361-25-045024.md) | [994](/filings/0001140361-26-010409.md) | [998](/filings/0001140361-26-023882.md) | [968](/filings/0001104659-26-104755.md) | [904](/filings/0001140361-25-045024.md) | [964](/filings/0001104659-26-104755.md) | [961](/filings/0001140361-26-023882.md) | [917](/filings/0001104659-26-104755.md) |
| Total assets | $m | [2,194](/filings/0001140361-24-048926.md) | [2,295](/filings/0001140361-25-010442.md) | [2,311](/filings/0001140361-25-021300.md) | [2,374](/filings/0001140361-25-033812.md) | [2,471](/filings/0001140361-25-045024.md) | [2,561](/filings/0001140361-26-010409.md) | [2,707](/filings/0001140361-26-023882.md) | [2,802](/filings/0001104659-26-104755.md) | [2,855](/filings/0001140361-25-045024.md) | [2,955](/filings/0001104659-26-104755.md) | [2,994](/filings/0001140361-26-023882.md) | [3,028](/filings/0001104659-26-104755.md) |
| Current liabilities | $m | [289](/filings/0001140361-24-048926.md) | [316](/filings/0001140361-25-010442.md) | [311](/filings/0001140361-25-021300.md) | [298](/filings/0001140361-25-033812.md) | [317](/filings/0001140361-25-045024.md) | [304](/filings/0001140361-26-010409.md) | [348](/filings/0001140361-26-023882.md) | [368](/filings/0001104659-26-104755.md) | [362](/filings/0001140361-25-045024.md) | [400](/filings/0001104659-26-104755.md) | [414](/filings/0001140361-26-023882.md) | [412](/filings/0001104659-26-104755.md) |
| Total liabilities | $m | [754](/filings/0001140361-24-048926.md) | [786](/filings/0001140361-25-010442.md) | [779](/filings/0001140361-25-021300.md) | [784](/filings/0001140361-25-033812.md) | [854](/filings/0001140361-25-045024.md) | [866](/filings/0001140361-26-010409.md) | [977](/filings/0001140361-26-023882.md) | [1,016](/filings/0001104659-26-104755.md) | [1,022](/filings/0001140361-25-045024.md) | [1,067](/filings/0001104659-26-104755.md) | [1,104](/filings/0001140361-26-023882.md) | [1,132](/filings/0001104659-26-104755.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,440](/filings/0001140361-24-048926.md) | [1,508](/filings/0001140361-26-010409.md) | [1,532](/filings/0001140361-25-033812.md) | [1,591](/filings/0001140361-25-045024.md) | [1,617](/filings/0001140361-25-045024.md) | [1,695](/filings/0001104659-26-104755.md) | [1,730](/filings/0001104659-26-104755.md) | [1,786](/filings/0001104659-26-104755.md) | [1,833](/filings/0001140361-25-045024.md) | [1,888](/filings/0001104659-26-104755.md) | [1,890](/filings/0001104659-26-104755.md) | [1,896](/filings/0001104659-26-104755.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.1 d](/filings/0001140361-24-048926.md) | [144 d](/filings/0001140361-26-010409.md) | [40.2](/filings/0001140361-25-021300.md) | [43.9 d](/filings/0001140361-25-033812.md) | [(4.4) d](/filings/0001140361-25-045024.md) | [148 d](/filings/0001140361-26-010409.md) | [28.7](/filings/0001140361-26-023882.md) | [80.7 d](/filings/0001104659-26-104755.md) | [4.8 d](/filings/0001140361-25-045024.md) | [182 d](/filings/0001140361-26-010409.md) | [45.5](/filings/0001140361-26-023882.md) | [108 d](/filings/0001104659-26-104755.md) |
| Capital expenditure | $m | [36.1 d](/filings/0001140361-24-048926.md) | [43.0 d](/filings/0001140361-26-010409.md) | [26.9](/filings/0001140361-25-021300.md) | [38.3 d](/filings/0001140361-25-033812.md) | [31.0 d](/filings/0001140361-25-045024.md) | [24.4 d](/filings/0001140361-26-010409.md) | [26.7](/filings/0001140361-26-023882.md) | [26.4 d](/filings/0001104659-26-104755.md) | [30.7 d](/filings/0001140361-25-045024.md) | [18.0 d](/filings/0001140361-26-010409.md) | [25.5](/filings/0001140361-26-023882.md) | [43.3 d](/filings/0001104659-26-104755.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [13.4 d](/filings/0001140361-24-048926.md) | [12.7 d](/filings/0001140361-26-010409.md) | [25.0](/filings/0001140361-25-021300.md) | [6.4 d](/filings/0001140361-25-033812.md) | [15.8 d](/filings/0001140361-25-045024.md) | [5.7 d](/filings/0001140361-26-010409.md) | [17.1](/filings/0001140361-26-023882.md) | [11.5 d](/filings/0001104659-26-104755.md) | [11.6 d](/filings/0001140361-25-045024.md) | [33.6 d](/filings/0001140361-26-010409.md) | [53.4](/filings/0001140361-26-023882.md) | [84.0 d](/filings/0001104659-26-104755.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.8](/filings/0001140361-23-056505.md) | [62.2](/filings/0001140361-24-029017.md) | [62.1](/filings/0001140361-24-039300.md) | [62.1](/filings/0001140361-24-048926.md) | [61.7](/filings/0001140361-25-021300.md) | [61.7](/filings/0001140361-25-033812.md) | [61.8](/filings/0001140361-25-045024.md) | [61.8](/filings/0001140361-26-023882.md) | [61.8](/filings/0001104659-26-104755.md) | [61.8](/filings/0001140361-25-045024.md) | [61.2](/filings/0001140361-26-023882.md) | [60.2](/filings/0001104659-26-104755.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,402,403 at 2026-08-26, from the cover of the [10-Q filed 2026-09-02](/filings/0001104659-26-104755.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.